Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Weld ED, Astemborski J, Kirk GD, Sulkowski MS, Katz S, Rothman R, Solomon SS, Matthews GV, Hsieh YH, Verma M, Traverso G, Swindells S, Owen A, Feld J, Flexner C, Mehta SH, Thomas DL.
Weld ED, et al. Among authors: thomas dl.
Clin Infect Dis. 2022 Aug 24;75(1):3-10. doi: 10.1093/cid/ciab913.
Clin Infect Dis. 2022.
PMID: 34699587
Free PMC article.